![Zach W. Hall](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zach W. Hall
Corporate Officer/Principal chez NeuroVentures Capital LLC
Postes actifs de Zach W. Hall
Sociétés | Poste | Début | Fin |
---|---|---|---|
NeuroVentures Capital LLC
![]() NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital LLC (NeuroVenture Capital) is a venture capital firm founded in 1999 by Mark A. Cochran, Daniel J. O'Connell and Hans von Celsing. The firm is headquartered in Charlottesville, Virginia. | Corporate Officer/Principal | - | - |
Historique de carrière de Zach W. Hall
Anciens postes connus de Zach W. Hall
Sociétés | Poste | Début | Fin |
---|---|---|---|
Nitrase Therapeutics, Inc.
![]() Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Directeur/Membre du Conseil | - | - |
The University of California, San Francisco | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Sectorielle
Finance | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
NeuroVentures Capital LLC
![]() NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital LLC (NeuroVenture Capital) is a venture capital firm founded in 1999 by Mark A. Cochran, Daniel J. O'Connell and Hans von Celsing. The firm is headquartered in Charlottesville, Virginia. | Finance |
Nitrase Therapeutics, Inc.
![]() Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Commercial Services |
- Bourse
- Insiders
- Zach W. Hall
- Expérience